Quinn Opportunity Partners’s Avidity Biosciences RNAM Stock Holding History

Quinn Opportunity Partners’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-100,000	Closed	-$7.21M	–	406
2025 Q4	$7.21M	Buy	+100,000	New	+$6.46M	0.3%	81

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Quinn Opportunity Partners's RNAM Position: Q1 2026 in Review

Quinn Opportunity Partners sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 100,000 shares — an estimated $7.21M sold.

Quinn Opportunity Partners first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $7.21M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Quinn Opportunity Partners reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Quinn Opportunity Partners sold 100,000 Avidity Biosciences shares in Q1 2026, an estimated $7.21M.
Quinn Opportunity Partners first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
Quinn Opportunity Partners's Avidity Biosciences position peaked at $7.21M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Quinn Opportunity Partners's 13F filing for Q1 2026, filed 15 May 2026.